Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Mesenchymal stem cells for the treatment of diabetes.

Pileggi A.

Diabetes. 2012 Jun;61(6):1355-6. doi: 10.2337/db12-0355. No abstract available.

2.

Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity.

Si Y, Zhao Y, Hao H, Liu J, Guo Y, Mu Y, Shen J, Cheng Y, Fu X, Han W.

Diabetes. 2012 Jun;61(6):1616-25. doi: 10.2337/db11-1141.

3.

Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.

Hao H, Liu J, Shen J, Zhao Y, Liu H, Hou Q, Tong C, Ti D, Dong L, Cheng Y, Mu Y, Liu J, Fu X, Han W.

Biochem Biophys Res Commun. 2013 Jul 5;436(3):418-23. doi: 10.1016/j.bbrc.2013.05.117. Epub 2013 Jun 11.

PMID:
23770360
4.

Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.

Katuchova J, Tothova T, Farkasova Iannaccone S, Toporcer T, Harvanova D, Hildebrand T, Kilik R, Bacenkova D, Frohlichova L, Rosocha J, Bobrov N, Radonak J.

J Surg Res. 2012 Nov;178(1):188-95. doi: 10.1016/j.jss.2012.02.028. Epub 2012 Mar 26.

PMID:
22480834
5.

Adipose-derived mesenchymal stem cells ameliorate hyperglycemia through regulating hepatic glucose metabolism in type 2 diabetic rats.

Xie M, Hao HJ, Cheng Y, Xie ZY, Yin YQ, Zhang Q, Gao JQ, Liu HY, Mu YM, Han WD.

Biochem Biophys Res Commun. 2017 Jan 29;483(1):435-441. doi: 10.1016/j.bbrc.2016.12.125. Epub 2016 Dec 21.

PMID:
28013047
6.

Engineered hair follicle mesenchymal stem cells overexpressing controlled-release insulin reverse hyperglycemia in mice with type L diabetes.

Wu C, Liu F, Li P, Zhao G, Lan S, Jiang W, Meng X, Tian L, Li G, Li Y, Liu JY.

Cell Transplant. 2015;24(5):891-907. doi: 10.3727/096368914X681919. Epub 2014 May 15.

PMID:
24835482
7.

Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes.

Xiao N, Zhao X, Luo P, Guo J, Zhao Q, Lu G, Cheng L.

Cytotherapy. 2013 Nov;15(11):1374-84. doi: 10.1016/j.jcyt.2013.06.013.

PMID:
24094489
8.

Transplantation of mesenchymal stem cells recruits trophic macrophages to induce pancreatic beta cell regeneration in diabetic mice.

Cao X, Han ZB, Zhao H, Liu Q.

Int J Biochem Cell Biol. 2014 Aug;53:372-9. doi: 10.1016/j.biocel.2014.06.003. Epub 2014 Jun 7.

PMID:
24915493
9.

Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes.

Bassi ÊJ, Moraes-Vieira PM, Moreira-Sá CS, Almeida DC, Vieira LM, Cunha CS, Hiyane MI, Basso AS, Pacheco-Silva A, Câmara NO.

Diabetes. 2012 Oct;61(10):2534-45. Epub 2012 Jun 11.

10.

Betacellulin overexpression in mesenchymal stem cells induces insulin secretion in vitro and ameliorates streptozotocin-induced hyperglycemia in rats.

Paz AH, Salton GD, Ayala-Lugo A, Gomes C, Terraciano P, Scalco R, Laurino CC, Passos EP, Schneider MR, Meurer L, Cirne-Lima E.

Stem Cells Dev. 2011 Feb;20(2):223-32. doi: 10.1089/scd.2009.0490. Epub 2010 Oct 26.

PMID:
20836700
11.

Authors' response.

Bhansali S, Kumar V, Saikia UN, Medhi B, Jha V, Bhansali A, Dutta P.

Indian J Med Res. 2016 Jan;143(1):112-3. No abstract available.

12.

Bone marrow mesenchymal stromal cells rescue cardiac function in streptozotocin-induced diabetic rats.

Monnerat-Cahli G, Trentin-Sonoda M, Guerra B, Manso G, Ferreira AC, Silva DL, Coutinho DC, Carneiro-Ramos MS, Rodrigues DC, Cabral-da-Silva MC, Goldenberg RC, Nascimento JH, Campos de Carvalho AC, Medei E.

Int J Cardiol. 2014 Feb 1;171(2):199-208. doi: 10.1016/j.ijcard.2013.12.013. Epub 2013 Dec 18.

PMID:
24374203
13.

Mesenchymal stroma cells improve hyperglycemia and insulin deficiency in the diabetic porcine pancreatic microenvironment.

Chang C, Niu D, Zhou H, Zhang Y, Li F, Gong F.

Cytotherapy. 2008;10(8):796-805. doi: 10.1080/14653240802461924.

PMID:
18979304
14.

Combinatorial human progenitor cell transplantation optimizes islet regeneration through secretion of paracrine factors.

Bell GI, Meschino MT, Hughes-Large JM, Broughton HC, Xenocostas A, Hess DA.

Stem Cells Dev. 2012 Jul 20;21(11):1863-76. doi: 10.1089/scd.2011.0634. Epub 2012 Apr 16.

PMID:
22309189
15.

Is the improved function of streptozotocin treated pancreas truly due to transdifferentiation/fusion of transplanted MSCs?

Bhartiya D.

Indian J Med Res. 2016 Jan;143(1):111-2. doi: 10.4103/0971-5916.178620. No abstract available.

16.

A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy.

El-Demerdash RF, Hammad LN, Kamal MM, El Mesallamy HO.

Regen Med. 2015;10(7):841-55. doi: 10.2217/rme.15.49. Epub 2015 Nov 6.

PMID:
26541176
17.

Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo.

Karaoz E, Okcu A, Ünal ZS, Subasi C, Saglam O, Duruksu G.

Cytotherapy. 2013 May;15(5):557-70. doi: 10.1016/j.jcyt.2013.01.005. Epub 2013 Feb 4.

PMID:
23388582
18.

Autografting of bone marrow mesenchymal stem cells alleviates streptozotocin‑induced diabetes in miniature pigs: real-time tracing with MRI in vivo.

Tang K, Xiao X, Liu D, Shen Y, Chen Y, Wang Y, Li B, Yu F, Ma D, Yan J, Liang H, Yang D, Weng J.

Int J Mol Med. 2014 Jun;33(6):1469-76. doi: 10.3892/ijmm.2014.1729. Epub 2014 Apr 7.

19.

Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.

Dao LT, Park EY, Lim SM, Choi YS, Jung HS, Jun HS.

Transplantation. 2014 Nov 27;98(10):1040-7. doi: 10.1097/TP.0000000000000388.

PMID:
25208321
20.

Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation.

Longoni B, Szilagyi E, Quaranta P, Paoli GT, Tripodi S, Urbani S, Mazzanti B, Rossi B, Fanci R, Demontis GC, Marzola P, Saccardi R, Cintorino M, Mosca F.

Diabetes Technol Ther. 2010 Jun;12(6):435-46. doi: 10.1089/dia.2009.0154.

PMID:
20470228

Supplemental Content

Support Center